| MOG antibody disease: a review of MOG antibody seropositive neuromyelitis optica spectrum disorder R Narayan, A Simpson, K Fritsche, S Salama, S Pardo, M Mealy, F Paul, ... Multiple sclerosis and related disorders 25, 66-72, 2018 | 208 | 2018 |
| Treatment of MOG-IgG-associated disorder with rituximab: an international study of 121 patients DH Whittam, A Cobo-Calvo, AS Lopez-Chiriboga, S Pardo, M Gornall, ... Multiple sclerosis and related disorders 44, 102251, 2020 | 127 | 2020 |
| Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion … ES Sotirchos, A Filippatou, KC Fitzgerald, S Salama, S Pardo, J Wang, ... Multiple Sclerosis Journal 26 (11), 1360-1371, 2020 | 88 | 2020 |
| MOG antibody–associated encephalomyelitis/encephalitis S Salama, M Khan, S Pardo, I Izbudak, M Levy Multiple Sclerosis Journal 25 (11), 1427-1433, 2019 | 87 | 2019 |
| Investigational drugs in development to prevent neuromyelitis optica relapses F Paul, O Murphy, S Pardo, M Levy Expert Opinion on Investigational Drugs 27 (3), 265-271, 2018 | 55 | 2018 |
| Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2 BA Trombetta, SE Kandigian, RR Kitchen, K Grauwet, PK Webb, GA Miller, ... BMC infectious diseases 21 (1), 580, 2021 | 24 | 2021 |
| Clinical characteristics of myelin oligodendrocyte glycoprotein antibody neuromyelitis optica spectrum disorder S Salama, S Pardo, M Levy Multiple sclerosis and related disorders 30, 231-235, 2019 | 22 | 2019 |
| Treatment of MOG-IgG-associated demyelination with Rituximab: a multinational study of 98 patients (S13. 003) D Whittam, A Cobo-Calvo, AS Lopez-Chiriboga, S Pardo, J Dodd, ... Neurology 90 (15 Supplement), 2018 | 15 | 2018 |
| Editorial on: Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder S Pardo, G Giovannoni, C Hawkes, J Lechner-Scott, E Waubant, M Levy Multiple sclerosis and related disorders 33, A1-A2, 2019 | 10 | 2019 |
| Familial monophasic acute transverse myelitis due to the pathogenic variant in VPS37A MA Mealy, TS Nam, SJ Pardo, CA Pardo, NL Sobreira, D Avramopoulos, ... Neurology Genetics 4 (1), 2018 | 5 | 2018 |
| A point-of-care diagnostic test for aquaporin-4 antibody seropositive neuromyelitis optica DR Rice, S Nishiyama, S Pardo, AMC Herrera, M Levy, FJ Mateen Multiple Sclerosis and Related Disorders 60, 103716, 2022 | 3 | 2022 |
| MOG-IgG is associated with better visual outcomes after optic neuritis than AQP4-IgG seropositivity, despite similar severity of inner retinal layer thinning (S21. 009) E Sotirchos, A Filippatou, S Salama, S Pardo, M Mealy, K Fitzgerald, ... Neurology 92 (15 Supplement), 2019 | 2 | 2019 |
| Acute flaccid myelitis in the 21st century: reminiscence of poliomyelitis or a new emergent disease M Levy, G Giovannoni, C Hawkes, J Lechner-Scott, E Waubant Multiple sclerosis and related disorders 29, A1-A2, 2019 | 1 | 2019 |
| Evaluation of a Point-of-Care Diagnostic Test for Aquaporin-4 Seropositive Neuromyelitis Optica Spectrum Disorder (S3. 008) D Rice, S Nishiyama, S Pardo, AMC Herrera, M Levy, F Mateen Neurology 98 (18 Supplement), 2022 | | 2022 |
| Corrigendum to “Editors’ Welcome”[Mult. Scler. Relat. Disord., 29 (2019) A1–A2] M Levy Multiple Sclerosis and Related Disorders 32, 138, 2019 | | 2019 |
| Familial Transverse Myelitis Associated with Mutation in VPS37A Gene (S44. 008) S Pardo, TS Nam, K Burns, M Levy Neurology 88 (16 Supplement), 2017 | | 2017 |
